| Thana Krisdakumtorn, DPM | |
|
795 El Camino Real, Palo Alto, CA 94301-2302 | |
| (650) 330-4529 | |
| Not Available |
| Full Name | Thana Krisdakumtorn |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 26 Years |
| Location | 795 El Camino Real, Palo Alto, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487765863 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0000X | Podiatrist - Sports Medicine | E4241 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sutter Bay Medical Foundation | 4284538778 | 2941 |
News Archive
The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.
Antibiotic resistance of the bacterium Staphylococcus aureus is responsible for 11,300 deaths a year in the United States alone - a figure that corresponds to half of all deaths caused by gram-positive resistant bacteria in that country.
Researchers at Wake Forest University Baptist Medical Center's Institute for Regenerative Medicine demonstrated the generation of a bioengineered human liver organoid using a liver bioscaffold made from an intact liver extracellular matrix, and filled (seeded) with primary human liver progenitor and endothelial cells.
September is National Childhood Obesity Awareness Month, drawing attention to the epidemic of obesity among children and adolescents in the United States. A multidisciplinary approach to assessment and intervention is crucial for effective weight management and should draw from the latest medical evidence, best practices, and innovative educational and policy initiatives, all of which are presented and debated in the new bimonthly, print and online journal Childhood Obesity, published by Mary Ann Liebert, Inc. The inaugural issue is available free online.
Illumina, Inc. today announced availability of its new TruSeq Custom Enrichment kits which enable researchers to economically design and target genomic regions of interest ranging from 700 kilobases (Kb) to 15 megabases (Mb) of cumulative DNA.
› Verified 5 days ago
| Provider Name | Sutter Bay Medical Foundation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1013950807 PECOS PAC ID: 4284538778 Enrollment ID: O20031125000909 |
News Archive
The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.
Antibiotic resistance of the bacterium Staphylococcus aureus is responsible for 11,300 deaths a year in the United States alone - a figure that corresponds to half of all deaths caused by gram-positive resistant bacteria in that country.
Researchers at Wake Forest University Baptist Medical Center's Institute for Regenerative Medicine demonstrated the generation of a bioengineered human liver organoid using a liver bioscaffold made from an intact liver extracellular matrix, and filled (seeded) with primary human liver progenitor and endothelial cells.
September is National Childhood Obesity Awareness Month, drawing attention to the epidemic of obesity among children and adolescents in the United States. A multidisciplinary approach to assessment and intervention is crucial for effective weight management and should draw from the latest medical evidence, best practices, and innovative educational and policy initiatives, all of which are presented and debated in the new bimonthly, print and online journal Childhood Obesity, published by Mary Ann Liebert, Inc. The inaugural issue is available free online.
Illumina, Inc. today announced availability of its new TruSeq Custom Enrichment kits which enable researchers to economically design and target genomic regions of interest ranging from 700 kilobases (Kb) to 15 megabases (Mb) of cumulative DNA.
› Verified 5 days ago
| Provider Name | Sutter Bay Medical Foundation |
|---|---|
| Provider Type | Part B Supplier - Ambulatory Surgical Center |
| Provider Identifiers | NPI Number: 1982845186 PECOS PAC ID: 4284538778 Enrollment ID: O20090501000247 |
News Archive
The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.
Antibiotic resistance of the bacterium Staphylococcus aureus is responsible for 11,300 deaths a year in the United States alone - a figure that corresponds to half of all deaths caused by gram-positive resistant bacteria in that country.
Researchers at Wake Forest University Baptist Medical Center's Institute for Regenerative Medicine demonstrated the generation of a bioengineered human liver organoid using a liver bioscaffold made from an intact liver extracellular matrix, and filled (seeded) with primary human liver progenitor and endothelial cells.
September is National Childhood Obesity Awareness Month, drawing attention to the epidemic of obesity among children and adolescents in the United States. A multidisciplinary approach to assessment and intervention is crucial for effective weight management and should draw from the latest medical evidence, best practices, and innovative educational and policy initiatives, all of which are presented and debated in the new bimonthly, print and online journal Childhood Obesity, published by Mary Ann Liebert, Inc. The inaugural issue is available free online.
Illumina, Inc. today announced availability of its new TruSeq Custom Enrichment kits which enable researchers to economically design and target genomic regions of interest ranging from 700 kilobases (Kb) to 15 megabases (Mb) of cumulative DNA.
› Verified 5 days ago
| Provider Name | Sutter Bay Medical Foundation |
|---|---|
| Provider Type | Part B Supplier - Ambulatory Surgical Center |
| Provider Identifiers | NPI Number: 1104067115 PECOS PAC ID: 4284538778 Enrollment ID: O20090501000456 |
News Archive
The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.
Antibiotic resistance of the bacterium Staphylococcus aureus is responsible for 11,300 deaths a year in the United States alone - a figure that corresponds to half of all deaths caused by gram-positive resistant bacteria in that country.
Researchers at Wake Forest University Baptist Medical Center's Institute for Regenerative Medicine demonstrated the generation of a bioengineered human liver organoid using a liver bioscaffold made from an intact liver extracellular matrix, and filled (seeded) with primary human liver progenitor and endothelial cells.
September is National Childhood Obesity Awareness Month, drawing attention to the epidemic of obesity among children and adolescents in the United States. A multidisciplinary approach to assessment and intervention is crucial for effective weight management and should draw from the latest medical evidence, best practices, and innovative educational and policy initiatives, all of which are presented and debated in the new bimonthly, print and online journal Childhood Obesity, published by Mary Ann Liebert, Inc. The inaugural issue is available free online.
Illumina, Inc. today announced availability of its new TruSeq Custom Enrichment kits which enable researchers to economically design and target genomic regions of interest ranging from 700 kilobases (Kb) to 15 megabases (Mb) of cumulative DNA.
› Verified 5 days ago
| Provider Name | Sutter Bay Medical Foundation |
|---|---|
| Provider Type | Part B Supplier - Ambulatory Surgical Center |
| Provider Identifiers | NPI Number: 1497996524 PECOS PAC ID: 4284538778 Enrollment ID: O20090506000097 |
News Archive
The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.
Antibiotic resistance of the bacterium Staphylococcus aureus is responsible for 11,300 deaths a year in the United States alone - a figure that corresponds to half of all deaths caused by gram-positive resistant bacteria in that country.
Researchers at Wake Forest University Baptist Medical Center's Institute for Regenerative Medicine demonstrated the generation of a bioengineered human liver organoid using a liver bioscaffold made from an intact liver extracellular matrix, and filled (seeded) with primary human liver progenitor and endothelial cells.
September is National Childhood Obesity Awareness Month, drawing attention to the epidemic of obesity among children and adolescents in the United States. A multidisciplinary approach to assessment and intervention is crucial for effective weight management and should draw from the latest medical evidence, best practices, and innovative educational and policy initiatives, all of which are presented and debated in the new bimonthly, print and online journal Childhood Obesity, published by Mary Ann Liebert, Inc. The inaugural issue is available free online.
Illumina, Inc. today announced availability of its new TruSeq Custom Enrichment kits which enable researchers to economically design and target genomic regions of interest ranging from 700 kilobases (Kb) to 15 megabases (Mb) of cumulative DNA.
› Verified 5 days ago
| Provider Name | Sutter Bay Medical Foundation |
|---|---|
| Provider Type | Part B Supplier - Ambulatory Surgical Center |
| Provider Identifiers | NPI Number: 1568851327 PECOS PAC ID: 4284538778 Enrollment ID: O20170927001545 |
News Archive
The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.
Antibiotic resistance of the bacterium Staphylococcus aureus is responsible for 11,300 deaths a year in the United States alone - a figure that corresponds to half of all deaths caused by gram-positive resistant bacteria in that country.
Researchers at Wake Forest University Baptist Medical Center's Institute for Regenerative Medicine demonstrated the generation of a bioengineered human liver organoid using a liver bioscaffold made from an intact liver extracellular matrix, and filled (seeded) with primary human liver progenitor and endothelial cells.
September is National Childhood Obesity Awareness Month, drawing attention to the epidemic of obesity among children and adolescents in the United States. A multidisciplinary approach to assessment and intervention is crucial for effective weight management and should draw from the latest medical evidence, best practices, and innovative educational and policy initiatives, all of which are presented and debated in the new bimonthly, print and online journal Childhood Obesity, published by Mary Ann Liebert, Inc. The inaugural issue is available free online.
Illumina, Inc. today announced availability of its new TruSeq Custom Enrichment kits which enable researchers to economically design and target genomic regions of interest ranging from 700 kilobases (Kb) to 15 megabases (Mb) of cumulative DNA.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thana Krisdakumtorn, DPM 325 Distel Cir, Los Altos, CA 94022-1408 Ph: (650) 853-2986 | Thana Krisdakumtorn, DPM 795 El Camino Real, Palo Alto, CA 94301-2302 Ph: (650) 330-4529 |
News Archive
The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs.
Antibiotic resistance of the bacterium Staphylococcus aureus is responsible for 11,300 deaths a year in the United States alone - a figure that corresponds to half of all deaths caused by gram-positive resistant bacteria in that country.
Researchers at Wake Forest University Baptist Medical Center's Institute for Regenerative Medicine demonstrated the generation of a bioengineered human liver organoid using a liver bioscaffold made from an intact liver extracellular matrix, and filled (seeded) with primary human liver progenitor and endothelial cells.
September is National Childhood Obesity Awareness Month, drawing attention to the epidemic of obesity among children and adolescents in the United States. A multidisciplinary approach to assessment and intervention is crucial for effective weight management and should draw from the latest medical evidence, best practices, and innovative educational and policy initiatives, all of which are presented and debated in the new bimonthly, print and online journal Childhood Obesity, published by Mary Ann Liebert, Inc. The inaugural issue is available free online.
Illumina, Inc. today announced availability of its new TruSeq Custom Enrichment kits which enable researchers to economically design and target genomic regions of interest ranging from 700 kilobases (Kb) to 15 megabases (Mb) of cumulative DNA.
› Verified 5 days ago
Elizabeth Anne Reilly, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Palo Alto, CA 94305 Phone: 650-723-4000 | |
Jonathan Jeah Seun, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Dr. Sandra Jay Loving, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Dr. Eghosa Isa, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 795 El Camino Real, Palo Alto, CA 94301 Phone: 650-853-2943 | |
Dr. Nancy Vilaysak Kim, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Aaron Z Handa, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 | |
Francis Dinh, Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3801 Miranda Ave, Palo Alto, CA 94304 Phone: 650-493-5000 |